QBFM
PBYI icon

QS Batterymarch Financial Management’s Puma Biotechnology PBYI Stock Holding History

QS Batterymarch Financial Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$6.37M Sell
26,700
-3,400
-11% -$698K 0.17% 175
2014
Q2 		$1.99M Buy
30,100
+8,300
+38% +$590K 0.05% 422
2014
Q1 		$2.27M Buy
+21,800
New +$2.56M 0.05% 473

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

QS Batterymarch Financial Management's PBYI Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its Puma Biotechnology (PBYI) stake by 11% in Q3 2014, selling an estimated $698K and leaving 26,700 shares worth $6.37M. The position accounts for 0.17% of the portfolio, ranked #175.

QS Batterymarch Financial Management first reported a position in PBYI in Q1 2014 and has held it in 3 quarters since. 183 funds tracked by Wall St. Rank hold PBYI as of Q3 2014.

  • QS Batterymarch Financial Management held 26,700 shares of Puma Biotechnology worth $6.37M as of Q3 2014.
  • QS Batterymarch Financial Management sold 3,400 Puma Biotechnology shares in Q3 2014, an estimated $698K.
  • Puma Biotechnology made up 0.17% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #175 holding.
  • QS Batterymarch Financial Management first reported a position in Puma Biotechnology in Q1 2014 and has held it in 3 quarters since.
  • 183 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.